Cargando…

Precision medicine in pantothenate kinase-associated neurodegeneration

Neurodegeneration with brain iron accumulation is a broad term that describes a heterogeneous group of progressive and invalidating neurologic disorders in which iron deposits in certain brain areas, mainly the basal ganglia. The predominant clinical symptoms include spasticity, progressive dystonia...

Descripción completa

Detalles Bibliográficos
Autores principales:	Álvarez-Córdoba, Mónica, Villanueva-Paz, Marina, Villalón-García, Irene, Povea-Cabello, Suleva, Suárez-Rivero, Juan M., Talaverón-Rey, Marta, Abril-Jaramillo, Javier, Vintimilla-Tosi, Ana Belén, Sánchez-Alcázar, José A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6425824/ https://www.ncbi.nlm.nih.gov/pubmed/30804242 http://dx.doi.org/10.4103/1673-5374.251203

Ejemplares similares

Down regulation of the expression of mitochondrial phosphopantetheinyl-proteins in pantothenate kinase-associated neurodegeneration: pathophysiological consequences and therapeutic perspectives
por: Álvarez-Córdoba, Mónica, et al.
Publicado: (2021)

Therapeutic approach with commercial supplements for pantothenate kinase-associated neurodegeneration with residual PANK2 expression levels
por: Álvarez-Córdoba, Mónica, et al.
Publicado: (2022)

Patient-Derived Cellular Models for Polytarget Precision Medicine in Pantothenate Kinase-Associated Neurodegeneration
por: Álvarez-Córdoba, Mónica, et al.
Publicado: (2023)

Alpha-lipoic acid supplementation corrects pathological alterations in cellular models of pantothenate kinase-associated neurodegeneration with residual PANK2 expression levels
por: Talaverón-Rey, Marta, et al.
Publicado: (2023)

Precision Medicine in Rare Diseases
por: Villalón-García, Irene, et al.
Publicado: (2020)

Pantothenate and L-Carnitine Supplementation Improves Pathological Alterations in Cellular Models of KAT6A Syndrome
por: Munuera-Cabeza, Manuel, et al.
Publicado: (2022)

Advances in mt-tRNA Mutation-Caused Mitochondrial Disease Modeling: Patients’ Brain in a Dish
por: Povea-Cabello, Suleva, et al.
Publicado: (2021)

Vicious cycle of lipid peroxidation and iron accumulation in neurodegeneration
por: Villalón-García, Irene, et al.
Publicado: (2022)

Atherosclerosis and Coenzyme Q(10)
por: Suárez-Rivero, Juan M., et al.
Publicado: (2019)

Coenzyme Q(10): Novel Formulations and Medical Trends
por: Pastor-Maldonado, Carmen J., et al.
Publicado: (2020)

Coenzyme Q(10) Analogues: Benefits and Challenges for Therapeutics
por: Suárez-Rivero, Juan M., et al.
Publicado: (2021)

From Mitochondria to Atherosclerosis: The Inflammation Path
por: Suárez-Rivero, Juan M., et al.
Publicado: (2021)

Mitochondria and Antibiotics: For Good or for Evil?
por: Suárez-Rivero, Juan M., et al.
Publicado: (2021)

Neurodegeneration, Mitochondria, and Antibiotics
por: Suárez-Rivero, Juan M., et al.
Publicado: (2023)

Pterostilbene in Combination With Mitochondrial Cofactors Improve Mitochondrial Function in Cellular Models of Mitochondrial Diseases
por: Suárez-Rivero, Juan M., et al.
Publicado: (2022)

UPR(mt) activation improves pathological alterations in cellular models of mitochondrial diseases
por: Suárez-Rivero, Juan M., et al.
Publicado: (2022)

Activation of the Mitochondrial Unfolded Protein Response: A New Therapeutic Target?
por: Suárez-Rivero, Juan M., et al.
Publicado: (2022)

Dynamic Reorganization of the Cytoskeleton during Apoptosis: The Two Coffins Hypothesis
por: Povea-Cabello, Suleva, et al.
Publicado: (2017)

mtUPR Modulation as a Therapeutic Target for Primary and Secondary Mitochondrial Diseases
por: Cilleros-Holgado, Paula, et al.
Publicado: (2023)

Pantothenate kinase-associated neurodegeneration
por: Hundallah, Khalid, et al.
Publicado: (2017)

Pantothenate kinase-associated neurodegeneration is not a synucleinopathy
por: Li, A, et al.
Publicado: (2013)

Proposed Therapies for Pantothenate-Kinase-Associated Neurodegeneration
por: Jackowski, Suzanne
Publicado: (2019)

Redesigning therapies for pantothenate kinase–associated neurodegeneration
por: Munshi, Muhammad I., et al.
Publicado: (2022)

Fosmetpantotenate Randomized Controlled Trial in Pantothenate Kinase–Associated Neurodegeneration
por: Klopstock, Thomas, et al.
Publicado: (2020)

Late Onset Atypical Pantothenate-Kinase-Associated Neurodegeneration
por: Diaz, Natalie
Publicado: (2013)

Deep Brain Stimulation for Pantothenate Kinase-Associated Neurodegeneration
por: Garcia-Ruiz, Pedro J., et al.
Publicado: (2015)

A therapeutic approach to pantothenate kinase associated neurodegeneration
por: Sharma, Lalit Kumar, et al.
Publicado: (2018)

Eye of the Tiger Sign in Pantothenate Kinase-Associated Neurodegeneration
por: Choayb, S., et al.
Publicado: (2021)

Genetic mutation spectrum of pantothenate kinase-associated neurodegeneration expanded by breakpoint sequencing in pantothenate kinase 2 gene
por: Yang, Dahae, et al.
Publicado: (2022)

Magnetic resonance imaging in pantothenate kinase-2-associated neurodegeneration
por: Singh, Paramdeep, et al.
Publicado: (2012)

Clinical Heterogeneity of Atypical Pantothenate Kinase-Associated Neurodegeneration in Koreans
por: Lee, Jae-Hyeok, et al.
Publicado: (2016)

Pantothenate kinase-associated neurodegeneration: Clinical aspects, diagnosis and treatments
por: Razmeh, Saeed, et al.
Publicado: (2018)

Diagnostic and clinical experience of patients with pantothenate kinase-associated neurodegeneration
por: Marshall, Randall D., et al.
Publicado: (2019)

Harmful Iron-Calcium Relationship in Pantothenate kinase Associated Neurodegeneration
por: Santambrogio, Paolo, et al.
Publicado: (2020)

Novel Compound Heterozygous Mutations in the Pantothenate Kinase 2 Gene in a Korean Patient with Atypical Pantothenate Kinase Associated Neurodegeneration
por: Kim, Sung-Hyouk, et al.
Publicado: (2009)

Case report: MR spectroscopy in pantothenate kinase-2 associated neurodegeneration
por: Parashari, Umesh C, et al.
Publicado: (2010)

Pantothenate kinase 2 deficiency: A neurodegeneration with brain iron accumulation
por: Yousaf, Muhammad, et al.
Publicado: (2015)

A pilot trial of deferiprone in pantothenate kinase-associated neurodegeneration patients
por: Rohani, Mohammad, et al.
Publicado: (2018)

Natural history and genotype‐phenotype correlation of pantothenate kinase‐associated neurodegeneration
por: Chang, Xuting, et al.
Publicado: (2020)

Atypical pantothenate kinase-associated neurodegeneration with variable phenotypes in an Egyptian family
por: Shalash, Ali S., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9jdchfmjd3rh8e6kl4a2our3m5